Publication | Open Access

Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy

InflammationTrough LevelsAnti-inflammatoryMedicineImmunologyGastroenterologyAutoimmunityCombination TherapyPharmacotherapyUlcerative ColitisPharmacology